Carl L. Heifetz

996 total citations
35 papers, 802 citations indexed

About

Carl L. Heifetz is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Carl L. Heifetz has authored 35 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 19 papers in Molecular Biology and 10 papers in Molecular Medicine. Recurrent topics in Carl L. Heifetz's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Cancer therapeutics and mechanisms (16 papers) and Antibiotic Resistance in Bacteria (10 papers). Carl L. Heifetz is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Cancer therapeutics and mechanisms (16 papers) and Antibiotic Resistance in Bacteria (10 papers). Carl L. Heifetz collaborates with scholars based in United States. Carl L. Heifetz's co-authors include John M. Domagala, Joseph P. Sanchez, Marland P. Hutt, T. F. MICH, Marjorie S. Solomon, Susan E. Hagen, J. M. DOMAGALA, Michael Cohen, Ashok K. Trehan and Martin A. Shapiro and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Carl L. Heifetz

32 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl L. Heifetz United States	16	412	341	312	198	98	35	802
Seigo Suzue Japan	9	572 1.4×	339 1.0×	533 1.7×	496 2.5×	118 1.2×	22	1.1k
M. D. GRUETT United States	7	378 0.9×	344 1.0×	335 1.1×	154 0.8×	91 0.9×	9	845
Dennis D. Keith United States	25	525 1.3×	435 1.3×	392 1.3×	152 0.8×	52 0.5×	54	1.1k
Masayuki Muroi Japan	15	435 1.1×	457 1.3×	327 1.0×	88 0.4×	54 0.6×	31	868
Patrick Laurin France	10	354 0.9×	392 1.1×	194 0.6×	85 0.4×	154 1.6×	12	719
Makoto Sunagawa Japan	18	280 0.7×	414 1.2×	309 1.0×	223 1.1×	133 1.4×	70	952
Masami Ohtsuka Japan	17	325 0.8×	550 1.6×	209 0.7×	289 1.5×	112 1.1×	27	945
David T. Davies United Kingdom	16	292 0.7×	384 1.1×	105 0.3×	189 1.0×	54 0.6×	32	750
Kei-Ichi Fujisawa United Kingdom	13	299 0.7×	195 0.6×	261 0.8×	114 0.6×	34 0.3×	36	604
Barton J. Bradbury United States	15	323 0.8×	257 0.8×	118 0.4×	130 0.7×	45 0.5×	20	600

Countries citing papers authored by Carl L. Heifetz

Since Specialization

Citations

This map shows the geographic impact of Carl L. Heifetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl L. Heifetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl L. Heifetz more than expected).

Fields of papers citing papers by Carl L. Heifetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl L. Heifetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl L. Heifetz. The network helps show where Carl L. Heifetz may publish in the future.

Co-authorship network of co-authors of Carl L. Heifetz

This figure shows the co-authorship network connecting the top 25 collaborators of Carl L. Heifetz. A scholar is included among the top collaborators of Carl L. Heifetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl L. Heifetz. Carl L. Heifetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shapiro, Martin A., et al.. (1998). Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model. Journal of Antimicrobial Chemotherapy. 41(3). 403–405. 6 indexed citations

Shapiro, Martin A., et al.. (1996). A novel rapid throughput phototolerance screen in mice. Journal of Pharmacological and Toxicological Methods. 36(4). 185–187. 1 indexed citations

Cohen, Michael, et al.. (1994). In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and β-lactamase stability. Diagnostic Microbiology and Infectious Disease. 18(1). 31–39. 17 indexed citations

Cohen, Michael, et al.. (1994). In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models. Diagnostic Microbiology and Infectious Disease. 18(1). 41–47. 1 indexed citations

Sanchez, Joseph P., et al.. (1992). Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonas activity. Journal of Medicinal Chemistry. 35(10). 1764–1773. 27 indexed citations

Sanchez, Joseph P., Alexander J. Bridges, J. M. DOMAGALA, et al.. (1992). New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk. Journal of Medicinal Chemistry. 35(2). 361–367. 20 indexed citations

Cohen, Michael, et al.. (1991). In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). Diagnostic Microbiology and Infectious Disease. 14(5). 403–415. 12 indexed citations

Cohen, Michael, et al.. (1991). In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent. Antimicrobial Agents and Chemotherapy. 35(1). 141–146. 28 indexed citations

Hagen, Susan E., J. M. DOMAGALA, Carl L. Heifetz, & James L. Johnson. (1991). Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids. Journal of Medicinal Chemistry. 34(3). 1155–1161. 27 indexed citations

10.

Cohen, Michael, et al.. (1991). In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagnostic Microbiology and Infectious Disease. 14(3). 245–258. 29 indexed citations

11.

Hagen, Susan E., John M. Domagala, Carl L. Heifetz, Joseph P. Sanchez, & Marjorie S. Solomon. (1990). New quinolone antibacterial agents. Synthesis and biological activity of 7-(3,3- or 3,4-disubstituted-1-pyrrolidinyl)quinoline-3-carboxylic acids. Journal of Medicinal Chemistry. 33(2). 849–854. 26 indexed citations

12.

Fritsch, P., et al.. (1989). Comparative chemotherapeutic acitivity of new fluorinated 4-quinolones and standard agents against a variety of bacteria in a mouse infection model. Journal of Antimicrobial Chemotherapy. 23(5). 729–736. 7 indexed citations

13.

Sanchez, Joseph P., John M. Domagala, Susan E. Hagen, et al.. (1988). Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids. Journal of Medicinal Chemistry. 31(5). 983–991. 108 indexed citations

14.

Domagala, John M., Carl L. Heifetz, Marland P. Hutt, et al.. (1988). 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure activity relationships at N1 for the quinolone antibacterials. Journal of Medicinal Chemistry. 31(5). 991–1001. 77 indexed citations

15.

Heifetz, Carl L., Paul Bien, Michael Cohen, et al.. (1988). Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates. Journal of Antimicrobial Chemotherapy. 21(suppl B). 29–42. 10 indexed citations

16.

Domagala, John M., Susan E. Hagen, Carl L. Heifetz, et al.. (1988). 7-Substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials. Journal of Medicinal Chemistry. 31(3). 503–506. 24 indexed citations

17.

Sugar, Alan M., Michael Cohen, Paul Bien, et al.. (1986). Treatment of Experimental Pseudomonas Corneal Ulcers With Enoxacin, a Quinolone Antibiotic. Archives of Ophthalmology. 104(8). 1230–1232. 5 indexed citations

18.

Woo, Peter W. K., Ernest D. Nicolaides, Marland P. Hutt, et al.. (1981). Semisynthetic penicillins. A structure-activity study of a new series of acyl amino acid-pyridone and pyrimidone amoxicillin analogs.. The Journal of Antibiotics. 34(7). 862–868. 5 indexed citations

19.

Kaltenbronn, James S., et al.. (1979). CI-867, a new broad-spectrum semisynthetic penicillin.. The Journal of Antibiotics. 32(6). 621–625. 6 indexed citations

20.

Heifetz, Carl L. & M. W. Fisher. (1973). Phenazopyridine-Sulfonamide Combination Antibacterial Therapy in Mice. Antimicrobial Agents and Chemotherapy. 3(1). 134–135. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact